Skip to main content
Equibles

RENAISSANCE TECHNOLOGIES LLC

Position in RNAC — Cartesian Therapeutics, Inc.

CIK 1037389 NEW YORK, NY
Back to RNAC Full portfolio

Position in RNAC

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$211,526
-$202,369 QoQ
Shares Held
20,300
-69.8% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#43
of 95 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RNAC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. RNAC ranks #249 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 EXEL
Exelixis, Inc.
 13,427,993 $730,617,099
2 CORT
Corcept Therapeutics Inc
 5,261,628 $457,498,554
3 INCY
Incyte Corp
 3,512,132 $398,135,283
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 320,008 $158,957,573
5 JAZZ
Jazz Pharmaceuticals plc
 562,073 $135,442,730
6 RPRX
Royalty Pharma plc
 1,935,800 $108,540,306
7 TVTX
Travere Therapeutics, Inc.
 1,833,079 $104,137,217
8 GMAB
Genmab A/S
 3,517,850 $96,635,339

All Filings in RNAC

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $211,526 20,300
2026-03-31 $413,895 67,300
2025-12-31 $296,331 41,100
2025-06-30 $202,605 19,500
2024-12-31 $247,158 13,800
2024-06-30 $460,574 17,052
2024-03-31 $359,839 553,600
2023-12-31 $356,764 517,800
2023-09-30 $769,559 726,000
2023-06-30 $1,122,802 1,002,502
2023-03-31 $1,491,590 1,073,087
2022-12-31 $1,384,086 1,224,855
2022-09-30 $1,484,363 905,100
2022-06-30 $770,783 588,384
2022-03-31 $1,833,191 1,490,400
2021-12-31 $1,552,411 476,200
2021-09-30 $1,090,751 262,200
2021-06-30 $1,790,089 428,251
2021-03-31 $1,287,362 284,500
2020-12-31 $2,942,835 971,233
2020-09-30 $1,230,972 496,360
2020-06-30 $3,229,477 1,137,140
2020-03-31 $3,554,477 1,474,887